Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Sell

Wall Street Data Solutions Rating

Neutral

B

Alector, Inc. Common Stock (ALEC)

Biological Products, (no Disgnostic Substances)

https://www.alector.com

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/07/2019

Market Cap

510,449,170

Shares Outstanding

84,140,000

Weighted SO

95,005,947

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

PASG --.--%

BDTX --.--%

TCRR --.--%

HARP --.--%

RVMD --.--%

BCEL --.--%

STOK --.--%

FIXX --.--%

GLUE --.--%

Beta

0.7230

Last Div

0.0000

Range

3.66-8.9

Chg

-0.0150

Avg Vol

672211

Mkt Cap

510449170

Exch

NASDAQ

Country

US

Phone

415 231 5660

DCF Diff

6.8665

DCF

-0.0165

Div Yield

0.0000

P/S

9.2347

EV Multiple

-2.7993

P/FV

3.3677

Div Yield %

0.0000

P/E

-3.1560

PEG

-0.3450

Payout

0.0000

Current Ratio

3.5191

Quick Ratio

3.5191

Cash Ratio

0.3219

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

119.0010

CCC

-119.0010

Gross Margin

0.7572

Op Margin

-3.3894

Pretax Margin

-2.8524

Net Margin

-2.9066

Eff Tax Rate

-0.0190

ROA

-0.2815

ROE

-1.0263

ROCE

-0.4429

NI/EBT

1.0190

EBT/EBIT

0.8416

EBIT/Rev

-3.3894

Debt Ratio

0.0633

D/E

0.2398

LT Debt/Cap

0.1545

Total Debt/Cap

0.1934

Int Coverage

-36.3152

CF/Debt

-6.0021

Equity Multi

3.7905

Rec Turnover

0.0000

Pay Turnover

3.0672

Inv Turnover

0.0000

FA Turnover

1.2746

Asset Turnover

0.0968

OCF/Share

-2.2421

FCF/Share

-2.2525

Cash/Share

5.2065

OCF/Sales

-3.9214

FCF/OCF

1.0047

CF Coverage

-6.0021

ST Coverage

-25.1833

CapEx Coverage

-214.8196

Div&CapEx Cov

-214.8196

P/BV

3.3677

P/B

3.3677

P/S

9.2347

P/E

-3.1560

P/FCF

-2.3441

P/OCF

-2.3393

P/CF

-2.3393

PEG

-0.3450

P/S

9.2347

EV Multiple

-2.7993

P/FV

3.3677

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 19, 09:20 Alector Announces Closing of Public Offering GlobeNewswire Inc. Jan 17, 08:54 Alector Announces Pricing of Public Offering of Common Stock Benzinga Dec 14, 13:29 Alector Upgraded, Analyst Sees High Reward Potential Ahead of Alzheimer's Disease Candidate's Phase 2 Results

Revenue Product Segmentation